This is a Validated Antibody Database (VAD) review about mouse Slc5a1, based on 6 published articles (read how Labome selects the articles), using Slc5a1 antibody in all methods. It is aimed to help Labome visitors find the most suited Slc5a1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Slc5a1 synonym: Sglt1; sodium/glucose cotransporter 1; Na(+)/glucose cotransporter 1; high affinity sodium-glucose cotransporter; solute carrier family 5, member 1; solute carrier family 5, member alpha 1
Abcam
rabbit polyclonal |
| Abcam Slc5a1 antibody (Abcam, ab14686) was used in immunohistochemistry on rat samples (fig 4). Eur J Histochem (2016) ncbi |
rabbit polyclonal |
| Abcam Slc5a1 antibody (Abcam, ab-14686) was used in western blot on human samples (fig 4). Fluids Barriers CNS (2015) ncbi |
rabbit polyclonal |
| In order to test the effect of hypo and hyperglycemic conditions on blood brain barrier integrity and endothelial function in vitro, Abcam Slc5a1 antibody (Abcam, ab14686) was used in immunocytochemistry on human samples at 1:200 and in western blot on human samples at 1:500. Fluids Barriers CNS (2014) ncbi |
EMD Millipore
rabbit polyclonal |
| EMD Millipore Slc5a1 antibody (Millipore, 07-1417) was used in western blot on human samples (fig s1e). Oncotarget (2015) ncbi |
rabbit polyclonal |
| EMD Millipore Slc5a1 antibody (Millipore, 07-1417) was used in immunocytochemistry on human samples at 1:100 (fig 1). Nat Med (2015) ncbi |
rabbit polyclonal |
| EMD Millipore Slc5a1 antibody (Millipore, 07-1417) was used in immunohistochemistry - paraffin section on rat samples at 1:100. Clin Sci (Lond) (2013) ncbi |
Articles Reviewed
- Kim J, Lee S, Lee J, Chun S, Kang B, Kwak S, et al. OGFOD1 is required for breast cancer cell proliferation and is associated with poor prognosis in breast cancer. Oncotarget. 2015;6:19528-41 pubmed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments